Screen for multiple bioterror agents and rule out most false alarms

20/20 BioResponse in Baltimore

Baltimore, MD, May 29–30, 2015—The 2015 IAFC Hazmat Conference was held in Baltimore, affording 20/20 BioResponse the opportunity to see many customers face to face, making every moment count. The conference was also a chance to forge new relationships for future mutual benefit. Many customers who had not seen the BioCheck Screening Test kit in… Continue Reading

Smiths Detection to Distribute Emergency Response Biological Screening Kits Globally

Partnership Leverages Smiths Detection’s Global Security Expertise and 20/20 BioResponse’s BioCheck® Technology to Enhance. Edgewood, MD, February 17. 2010 – Smiths Detection today announces a world-wide distribution agreement with 20/20 BioResponse for its BioCheck powder screening test kits. The partnership adds a low-cost, highly-effective biological threat assessment tool to strengthen Smiths Detection’s portfolio of proven… Continue Reading

U.S. Army Validates BIOCHECK ® As An Effective First Line Test For Suspicious Powders

Review of tools to detect biological threats published by U.S. Army ECBC in December 2009 edition of The Journal of Hazardous Materials, 20/20 BioCheck® was found to easily and accurately determine the presence of a potential biological threat and differentiate between toxic and harmless hoax powders. Rockville, MD. – December 3, 2009 – The U.S.… Continue Reading

SAFETY Act Designation awarded to BioCheck product

The BioCheck® Powdered Screening Test Kit, a product of 20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. has earned designation as a Qualified Anti-Terrorism Technology under the U.S. Department of Homeland Security (DHS)’s SAFETY Act . The SAFETY (Support Anti-terrorism by Fostering Effective Technologies) Act encourages the development and rapid deployment of anti-terrorism technologies… Continue Reading